References
- Uka K, Aikata H, Takaki S, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 2007;13:414-420. https://doi.org/10.3748/wjg.v13.i3.414
- Lo CM, Lai EC, Fan ST, Choi TK, Wong J. Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg 1994;81:1019-1021. https://doi.org/10.1002/bjs.1800810730
- Poon RT, Fan ST, O'Suilleabhain CB, Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 2002;195:311-318. https://doi.org/10.1016/S1072-7515(02)01226-7
- Yang Y, Nagano H, Ota H, et al. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery 2007;141:196-202. https://doi.org/10.1016/j.surg.2006.06.033
- Kumar A, Schneider V. Metastases to the uterus from extrapelvic primary tumors. Int J Gynecol Pathol 1983;2:134-140. https://doi.org/10.1097/00004347-198302000-00004
- Katyal S, Oliver JH 3rd, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000;216:698-703. https://doi.org/10.1148/radiology.216.3.r00se24698
- Natsuizaka M, Omura T, Akaike T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 2005;20:1781-1787. https://doi.org/10.1111/j.1440-1746.2005.03919.x
- Charache H. Metastatic carcinoma in the uterus. Am J Surg 1941;53:152-157. https://doi.org/10.1016/S0002-9610(41)90463-4
- Ryo E, Sato T, Takeshita S, Ayabe T, Tanaka F. Uterine metastasis from hepatocellular carcinoma: a case report. Int J Gynecol Cancer 2006;16:1894-1896. https://doi.org/10.1111/j.1525-1438.2006.00668.x
- Kang WD, Kim CH, Cho MK, et al. Hepatocellular carcinoma presenting as uterine metastasis. Cancer Res Treat 2008;40:141-144. https://doi.org/10.4143/crt.2008.40.3.141
- Park UJ, Kim YH, Kang KJ, Lim TJ. Risk factors for early recurrence after surgical resection for hepatocellular carcinoma. Korean J Hepatol 2008;14:371-380. https://doi.org/10.3350/kjhep.2008.14.3.371
- Kanda M, Tateishi R, Yoshida H, et al. Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors. Liver Int 2008;28:1256-1263. https://doi.org/10.1111/j.1478-3231.2008.01864.x
- Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:417-422.
- Nobuoka D, Kato Y, Gotohda N, et al. Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma. Oncol Rep 2010;24:521-528.
- Shin WY, Suh KS, Kim T, Jeon YM, Yi NJ, Lee KU. Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein level? Korean J Hepatol 2010;16: 168-175. https://doi.org/10.3350/kjhep.2010.16.2.168
- Stemmermann GN. Extrapelvic carcinoma metastatic to the uterus. Am J Obstet Gynecol 1961;82:1261-1266. https://doi.org/10.1016/S0002-9378(16)36251-2
- So BJ, Bekaii-Saab T, Bloomston MA, Patel T. Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: a case report. J Hematol Oncol 2008;1:18. https://doi.org/10.1186/1756-8722-1-18
- Yeganeh M, Finn RS, Saab S. Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib. Am J Transplant 2009;9:2851-2854. https://doi.org/10.1111/j.1600-6143.2009.02860.x